Search Videos and More
News
Transperineal Biopsy
For some men who need a biopsy to test for prostate cancer, Fox Chase Cancer Center now offers an alternative approach that is safer, with significantly lower risks of infection, and potentially higher rate of tumor detection. This new procedure, called transperineal biopsy, uses an external entry point in the perineum area, instead of the more traditional transrectal (through the rectum wall) approach. A rectal ultrasound probe helps the physician guide the biopsy instrument to reach more areas in the prostate, including the anterior region that is more difficult to access using the transrectal method.
News
Fox Chase Recruiting for Ongoing Phase-1 Trial of Targeted Therapy for Ewing Sarcoma
The phase-1 trial will test a new targeted therapy called seclidemstat in patients with relapsed or refractory Ewing sarcoma or Ewing-related Sarcomas.
News
High Expectations for Adoptive Cell Therapy for Treatment of Solid Tumors
A partnership between the Fox Chase solid tumor oncologists and their colleagues in bone marrow transplantation tests the potential of adoptive cell therapies for the treatment of solid tumors.
News
Adjuvant Olaparib a Win for High-Risk, BRCA-Mutant Early Breast Cancer
Researchers at Fox Chase Cancer Center discuss the benefits of the PARP inhibitor olaparib for women with high-risk, HER2-negative, BRCA-mutant early breast cancer.
Video
How to Perform Device-Free, Free-Handed Transperineal Prostate Biopsy
Fox Chase Cancer Center’s urologic oncology group shares an educational video that provides instruction on how to perform a device-free, free-handed transperineal prostate biopsy.
News
Peritoneal Surface Malignancies
News
Urology Team Continues Focus on Improving Kidney Cancer Surgery Outcomes
Two new collaborative publications focus on treatment decisions for patients with renal masses.
News
Fox Chase Genitourinary Cancer Physicians Gain National Recognition
Three members of Fox Chase Cancer Center’s Genitourinary Cancer Program – Elizabeth Plimack, MD, MS; Alexander Kutikov, MD, FACS; and Benjamin Miron, MD -- have gained national recognition for their work advancing the care of patients with genitourinary cancers.
News
Clinical Nurse Manager, Rebecca Farrell, MSN, RN, Keeps Calm, Carries On Amidst COVID-19 Pandemic
As patient care adapted to the restrictions of the COVID-19 pandemic, Farrell continued to ensure that patients had access to cutting-edge care.
News
Two Studies Provide Answers on Best Approach to Bladder Cancer Treatment
Evaluating the current standards of care for cystectomy yielded interesting results on when it is most appropriate.
News
Fox Chase Offers Ureteral Mitomycin Gel for Low-Grade Upper Tract Urothelial Carcinoma
Jelmyto provides an alternative treatment option for low-grade UTUC and may spare some patients from nephrectomy. A recent study of the treatment showed a 58% complete response rate.
News
Immunotherapy for Never Smokers with Non-Small Cell Lung Cancer
To further evaluate the use of immunotherapy for these patients with NSCLC, Treat is serving as a primary investigator in a nationwide Phase II, double-arm, randomized clinical trial of treatment-naïve never smokers without the EGFR driver mutation and individuals with EGFR driver mutations for whom standard-of-care therapy with tyrosine kinase inhibitors have failed.